HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Yves Picard Selected Research

Persistent Mullerian duct syndrome

10/2019A mutation inactivating the distal SF1 binding site on the human anti-Müllerian hormone promoter causes persistent Müllerian duct syndrome.
7/2019Persistent Müllerian duct syndrome: an update.
1/2019Persistent Müllerian Duct Syndrome: A Rare But Important Etiology of Inguinal Hernia and Cryptorchidism.
1/2013Anti-müllerian hormone: a valuable addition to the toolbox of the pediatric endocrinologist.
1/2012Mutations of the AMH type II receptor in two extended families with persistent Müllerian duct syndrome: lack of phenotype/genotype correlation.
8/2009Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
7/2005AMH and AMH receptor defects in persistent Müllerian duct syndrome.
3/2004Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Yves Picard Research Topics

Disease

8Persistent Mullerian duct syndrome
10/2019 - 03/2004
5Neoplasms (Cancer)
01/2013 - 07/2005
3Choriocarcinoma
06/2013 - 01/2012
3Disorders of Sex Development (Intersexuality)
01/2013 - 10/2012
1Invasive Hydatidiform Mole (Invasive Mole)
06/2013
1Hydatidiform Mole (Molar Pregnancy)
06/2013
1Anovulation
03/2013
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
03/2013
1Turner Syndrome (Turner's Syndrome)
01/2013
1Hypogonadism (Hypergonadotropic Hypogonadism)
10/2012
1Chromosome Aberrations (Chromosome Abnormalities)
09/2012
1Granulosa Cell Tumor
01/2012
1Androgen-Insensitivity Syndrome (Testicular Feminization)
05/2009
1Follicular Cyst (Follicular Cysts)
08/2008
1Cysts
08/2008
1Hypertrophy
08/2008
1Polyostotic Fibrous Dysplasia (McCune Albright Syndrome)
12/2006
1Precocious Puberty
12/2006
1Developmental Bone Diseases (Bone Dysplasia)
12/2006

Drug/Important Bio-Agent (IBA)

7Hormones (Hormone)IBA
10/2019 - 08/2008
4anti-Mullerian hormone receptorIBA
07/2019 - 07/2005
2AndrogensIBA
01/2013 - 10/2012
2DNA (Deoxyribonucleic Acid)IBA
09/2012 - 01/2012
2Anti-Mullerian HormoneIBA
01/2012 - 03/2004
2Testosterone (Sustanon)FDA Link
05/2009 - 08/2008
2Proteins (Proteins, Gene)FDA Link
12/2006 - 03/2004
1Cadherins (E-Cadherin)IBA
06/2013
1CateninsIBA
06/2013
1LuteinIBA
03/2013
1MicroRNAs (MicroRNA)IBA
09/2012
1AntigensIBA
01/2012
1Inhibins (Inhibin)IBA
01/2012
1Peptides (Polypeptides)IBA
01/2012
1LigandsIBA
08/2009
1GonadotropinsIBA
05/2009
1ProgesteroneFDA LinkGeneric
08/2008
1Messenger RNA (mRNA)IBA
08/2008
1SteroidsIBA
08/2008
1steroidogenic acute regulatory proteinIBA
08/2008
1Estradiol (Delestrogen)FDA LinkGeneric
08/2008
1AntralIBA
08/2008
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2006
1Phosphotransferases (Kinase)IBA
07/2005
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
07/2005
1Activins (Activin)IBA
07/2005
1Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA
07/2005

Therapy/Procedure

1Aftercare (After-Treatment)
01/2013
1Therapeutics
01/2012